2019
DOI: 10.1016/bs.ircmb.2018.10.003
|View full text |Cite
|
Sign up to set email alerts
|

Nucleic Acid Sensing in Mammals and Plants: Facts and Caveats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
35
0
4

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 28 publications
(41 citation statements)
references
References 385 publications
2
35
0
4
Order By: Relevance
“…[1][2][3][4][5][6][7][8] Nonetheless, attention on alternative immunotherapeutic approaches has remained high, at least in part reflecting: (1) the relatively small fraction of patients responding to ICBs employed as single agents; [9][10][11] (2) the considerable side effects associated with some ICBs, especially when combined with each other; [12][13][14][15] and (3) the economic burden of ICB-based immunotherapy. 16,17 Besides monoclonal antibodies that operate as agonists of co-stimulatory receptors on immune effector cells, [18][19][20] such immunotherapeutic agents include small molecules that trigger Toll-like receptor (TLR) signaling, [21][22][23][24][25][26][27][28][29] de facto providing antigen-presenting cells (APCs) such as dendritic cells (DCs) [30][31][32] with adjuvant-like, maturation signals that support the initiation of anticancer immunity (rather than tolerance). 22,[33][34][35][36][37][38] TLRs are evolutionary conserved pattern recognition receptors (PRRs) localized at the cell surface or in endosomal compartments, and act as key mediators of innate immunity.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…[1][2][3][4][5][6][7][8] Nonetheless, attention on alternative immunotherapeutic approaches has remained high, at least in part reflecting: (1) the relatively small fraction of patients responding to ICBs employed as single agents; [9][10][11] (2) the considerable side effects associated with some ICBs, especially when combined with each other; [12][13][14][15] and (3) the economic burden of ICB-based immunotherapy. 16,17 Besides monoclonal antibodies that operate as agonists of co-stimulatory receptors on immune effector cells, [18][19][20] such immunotherapeutic agents include small molecules that trigger Toll-like receptor (TLR) signaling, [21][22][23][24][25][26][27][28][29] de facto providing antigen-presenting cells (APCs) such as dendritic cells (DCs) [30][31][32] with adjuvant-like, maturation signals that support the initiation of anticancer immunity (rather than tolerance). 22,[33][34][35][36][37][38] TLRs are evolutionary conserved pattern recognition receptors (PRRs) localized at the cell surface or in endosomal compartments, and act as key mediators of innate immunity.…”
Section: Introductionmentioning
confidence: 99%
“…22,[33][34][35][36][37][38] TLRs are evolutionary conserved pattern recognition receptors (PRRs) localized at the cell surface or in endosomal compartments, and act as key mediators of innate immunity. 26,[39][40][41][42][43] As a family, TLRs play a crucial role in ensuring a first line of defense against pathogens, largely based on their ability to respond to conserved microbial structures commonly referred to as microbe-associated molecular patterns (MAMPs) by initiating the secretion of bioactive factors including numerous cytokines. 40,[44][45][46][47] Alongside this pristine antimicrobial function, TLRs also respond to a number of endogenous cues commonly referred to damage-associated molecular patterns (DAMPs), which are critical for the detection of cell stress and death as immunogenic in sterile conditions.…”
Section: Introductionmentioning
confidence: 99%
“…Briefly, human HMGB1 binds in the nucleus to DNA, facilitating nucleosome formation and transcription factor binding (Thomas and Travers, 2001;Lotze and Tracey, 2005). Upon its release outside the cell, it can be recognized by various cell surface receptors (Heil and Vega-Muñoz, 2019). In metazoans, HMGB1 facilitates tissue repair and healing by promoting the switch of macrophages to a tissue-healing phenotype (Bianchi et al, 2017).…”
Section: High Mobility Group Box Proteinsmentioning
confidence: 99%
“…Intriguingly, the ability of non-selfderived DNA to trigger an immune response is lower or undetectable than the ones induced by self-derived DNA (Duran-Flores and Heil, 2018), suggesting a species-specific perception mechanism that discriminates self-derived DNA from non-self DNA. To date, no DNA receptor has been identified in plant cells, and none of the receptors that are known from mammals discriminate between self and non-self DNA (Heil and Vega-Muñoz, 2019). Extracellular DNA present on plant root tips is required for defense against a necrotrophic fungus (Wen et al, 2009), and it was recently reported that secreted DNases by a fungal pathogen (Cochliobolus heterostrophus) and a herbivore (Laodelphax striatellus) serve as effectors that suppress DNA-dependent plant immunity, reinforcing the biological relevance of DNA as a DAMP in plants (Huang et al, 2019).…”
Section: Dnamentioning
confidence: 99%
“…In plant cells, there is emerging evidence of the connection between DAMPs and the DNA damage response (DDR), as nucleic acid recognition represents a fundamental step in host defense. Plants have been documented to perceive both extracellular DNA and RNA [1214]. Toll-like receptors (TLRs) play a central role in the preferential recognition and binding of extracellular DNA in animals [1519].…”
Section: Introductionmentioning
confidence: 99%